All Vaccinology articles – Page 18
-
NewsNew recommendation on meningitis vaccines for infants in sub-Saharan Africa
An IDCRC study assessing the meningococcal pentavalent (five in one) vaccine for infants in Africa shows vaccine provides protection against meningococcal meningitis.
-
NewsDoes COVID-19 or COVID-19 vaccination worsen migraines?
New research indicates that COVID-19 and COVID-19 vaccination have negligible effects on migraine severity.
-
NewsVersatile vaccine candidate fights measles, mumps and Covid
Altered measles and mumps viruses could be used as a platform to create a trivalent COVID-19 vaccine that triggers immunity to multiple variant strains of the SARS-CoV-2 virus, new research in animals suggests. The study builds upon previous studies that involved inserting a highly stable segment of ...
-
NewsResearchers develop better way to test vaccines against bird flu
Researchers have developed an improved way to test potential vaccines against bird flu.
-
NewsNobel Prize goes to researchers whose discoveries paved way for mRNA vaccines
The 2023 Nobel Prize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
-
NewsBactiVac funded to develop bacterial vaccines in global fight against AMR
The UK government has awarded the University of Birmingham-hosted Bacterial Vaccines Network (BactiVac) £1.4 million in funding to accelerate the development of bacterial vaccines as part of the fight against antimicrobial resistance (AMR).
-
NewsValneva announces new IXIARO® supply contract with the US government
Specialty vaccine company Valneva SE has announced the signing of a new $32 million contract with the United States Department of Defense for the supply of its Japanese encephalitis vaccine, IXIARO®.
-
NewsNew vaccine technology could protect from future viruses and variants
Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals.
-
NewsNanoparticle vaccine candidate shows promise against emerging tick-borne virus
Researchers have used nanoparticles to develop a potential vaccine candidate against Dabie Bandavirus, formerly known as Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a tick-borne virus that has no prevention, treatment or cure.
-
CareersIgnoring the rise of anti-science could usher back once-deadly diseases
As a wave of anti-science sentiment sweeps the globe, scientists need to speak up, says paediatric vaccine scientist Dr Peter Hotez in an interview with The Microbiologist as he launches his new book.
-
NewsClinical trial of HIV vaccine begins in United States and South Africa
A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial will evaluate a novel vaccine known as VIR-1388 for its safety and ability to induce an HIV-specific immune response in people. Source: NIAID Transmission electron micrograph ...
-
NewsRapid acting oral vaccines are on the way
Researchers studying SARS-CoV-2 may have developed new methods to administer vaccines orally, which would be both easier to administer and more effective at combatting illnesses.
-
NewsMpox infections less severe in those vaccinated or previously infected
A new study has shown mpox (formerly known as monkeypox) infections to be less severe among those who are vaccinated or had a previous infection in 2022, underlining the importance and effectiveness of vaccination.
-
NewsThousands of children’s operations ’will have to be cancelled’ this winter as UK government delays RSV vaccine
Babies could be needlessly hospitalised this winter because the government has delayed a vaccine that protects them from a life-threatening virus, the UK’s top children’s doctor has warned.
-
NewsStudy reveals how leishmaniasis vaccines work at molecular level
Researchers have determined how these vaccine candidates for leishmaniasis prompt molecular-level changes in host cells that have specific roles in helping generate the immune response.
-
NewsMap the coronavirus spike protein for insight into vaccine development
A new study has found that the fusion peptide in the spike protein plays a more invasive role in fusing the virus to the cell than previously thought, which is significant in understanding how infection occurs.
-
NewsStudy helps explain SARS-CoV-2 variants’ rapid spread
Omicron variants, which circulated quickly around the globe, bind to cells more avidly and evade antibodies more efficiently than earlier variants, new research reveals.
-
NewsTexas Biomed partners with Scancell to test novel COVID vaccine
A DNA-based vaccine is very effective at protecting against COVID-19, according to a joint preclinical study by Scancell Ltd and Texas Biomedical Research Institute (Texas Biomed).
-
NewsAttack on Mac1 Covid protein may lead to longer lasting live-attenuated vaccine
Research could hasten development of a new class of vaccines aimed at SARS-CoV-2, the virus that causes COVID-19.
-
FeaturesUnder the microscope: Japanese encephalitis
JEV is one of the leading causes of viral encephalitis globally, widespread across Asia-Pacific and endemic in 24 countries of south and southeast Asia.